Exergaming for Aging Adults (MouvMat Trial)

N/A

Recruiting

Led By Charlene Chu, PhD

Research Sponsored by University of Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up following the completion of the intervention (6 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new gaming technology called MouvMat for older adults living in long-term care homes. The technology allows participants to play games by stepping on or tapping the surface. The objective

Who is the study for?

This trial is for older adults aged 65+ living in long-term care homes, their caregivers, and LTC staff with experience in physical or recreational activities. Participants must speak English and be able to consent or have someone who can consent for them.

What is being tested?

The study tests MouvMat Exergaming technology against standard recreational activities. It aims to see if this interactive gaming improves mobility, cognitive function, and social interaction among the elderly in LTC homes.

What are the potential side effects?

While not explicitly mentioned, potential side effects may include fatigue or minor physical discomfort from new activity routines. The exergaming intervention is designed to be safe for older adults.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ following the completion of the intervention (6 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~following the completion of the intervention (6 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and following the completion of the intervention (6 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adverse events (e.g. injury) related to exergame use

Change in mean mobility scores on the 2-Minute Walk Test

Change in mean mobility scores on the Timed-up-and-Go test

+1 more

Secondary study objectives

Change in errors made on an alternating sequences test

Change in mean alternating attention scores on the Trail Making Test B

Change in mean basic attention/psychomotor speed on the Trail Making Test A

+4 more

Other study objectives

Acceptability on a version of the modified Treatment Evaluation Inventory (m-TEI) adapted for exergame use

Semi-structured interviews to evaluate the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard Recreational ProgrammingExperimental Treatment1 Intervention

A control group will meet on a similar schedule as the MouvMat group for standard recreational programming conducted by onsite recreational therapists. The same RA from the experimental group will collect outcome measurements from control group participants.

Group II: MouvMat ExergamingExperimental Treatment1 Intervention

Older adults in the intervention group will participate in a 6-week, 3 times per week, 45 minutes per session exercise program involving use of the MouvMat. Each resident from the intervention group will engage with the exergame supervised by a qualified and trained RA. Each intervention session will involve groups of 4-5 participants, with participants taking turns. An RA blinded to participants' condition will collect the outcome data.

Do I qualify?Apply below to find out